ACE and diabetes mellitus: The ACE2/Ang-(1-7)/Mas receptor pathway is known to oppose the detrimental effects of ACE/Ang II/AT1 receptor in diabetes-induced cardiovascular complications [16–18] and recent evidence suggests it may also be involved in DMIED [7, 12–14, 19].